Free Trial

Forsta AP Fonden Sells 187,100 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Healthpeak Properties logo with Finance background

Key Points

  • Forsta AP Fonden reduced its stake in Healthpeak Properties by 42.2%, now holding 256,700 shares worth approximately $5.19 million.
  • Healthpeak Properties reported $0.46 EPS for the last quarter, meeting estimates, but saw a 0.2% decrease in revenue year-over-year.
  • The company announced a monthly dividend of $0.1017 per share, yielding 7.2% annually, with a high dividend payout ratio of 508.33%.
  • Looking to export and analyze Healthpeak Properties data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Forsta AP Fonden decreased its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 42.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 256,700 shares of the real estate investment trust's stock after selling 187,100 shares during the period. Forsta AP Fonden's holdings in Healthpeak Properties were worth $5,190,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in DOC. Parallel Advisors LLC boosted its stake in Healthpeak Properties by 4.2% during the 1st quarter. Parallel Advisors LLC now owns 13,980 shares of the real estate investment trust's stock valued at $283,000 after purchasing an additional 561 shares during the last quarter. Applied Finance Capital Management LLC raised its stake in shares of Healthpeak Properties by 3.4% in the first quarter. Applied Finance Capital Management LLC now owns 17,648 shares of the real estate investment trust's stock worth $357,000 after purchasing an additional 577 shares during the last quarter. Townsquare Capital LLC lifted its holdings in shares of Healthpeak Properties by 5.9% during the fourth quarter. Townsquare Capital LLC now owns 10,461 shares of the real estate investment trust's stock valued at $212,000 after purchasing an additional 584 shares in the last quarter. AssuredPartners Investment Advisors LLC boosted its position in shares of Healthpeak Properties by 3.1% during the first quarter. AssuredPartners Investment Advisors LLC now owns 22,088 shares of the real estate investment trust's stock valued at $447,000 after buying an additional 666 shares during the last quarter. Finally, TCTC Holdings LLC increased its holdings in Healthpeak Properties by 124.3% in the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock worth $27,000 after buying an additional 751 shares in the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Tommy G. Thompson acquired 5,777 shares of Healthpeak Properties stock in a transaction dated Wednesday, May 28th. The stock was purchased at an average cost of $17.27 per share, with a total value of $99,768.79. Following the completion of the purchase, the director directly owned 144,290 shares in the company, valued at approximately $2,491,888.30. This trade represents a 4.17% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Scott M. Brinker bought 1,490 shares of the stock in a transaction that occurred on Monday, August 4th. The shares were purchased at an average price of $16.83 per share, for a total transaction of $25,076.70. Following the purchase, the chief executive officer owned 211,906 shares in the company, valued at $3,566,377.98. This represents a 0.71% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 14,560 shares of company stock worth $249,898. 0.23% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on DOC shares. Argus reissued a "buy" rating and issued a $25.00 target price on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Scotiabank cut shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and decreased their price objective for the company from $21.00 to $19.00 in a report on Tuesday, July 29th. Robert W. Baird set a $21.00 price objective on shares of Healthpeak Properties and gave the company an "outperform" rating in a research report on Wednesday, July 30th. Wedbush cut their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Finally, Wall Street Zen lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $23.00.

View Our Latest Research Report on DOC

Healthpeak Properties Stock Performance

Shares of NYSE:DOC traded up $0.23 during midday trading on Tuesday, hitting $17.00. The company had a trading volume of 8,526,372 shares, compared to its average volume of 8,000,556. Healthpeak Properties, Inc. has a 12-month low of $16.63 and a 12-month high of $23.26. The company has a fifty day moving average of $17.63 and a two-hundred day moving average of $18.55. The company has a market cap of $11.81 billion, a price-to-earnings ratio of 70.84, a PEG ratio of 2.14 and a beta of 1.05. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. The business had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%. Healthpeak Properties's revenue for the quarter was down .2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.45 earnings per share. On average, equities research analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Tuesday, September 30th. Investors of record on Friday, September 19th will be issued a $0.1017 dividend. This represents a c) annualized dividend and a yield of 7.2%. The ex-dividend date of this dividend is Friday, September 19th. Healthpeak Properties's dividend payout ratio is currently 508.33%.

Healthpeak Properties Company Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Featured Articles

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines